CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Emtricitabine/tenofovir disoproxil fumarate

Last Updated: July 7, 2008
Result type: Reports
Project Number: SF0138-000
Product Line: Reimbursement Review

Generic Name: Emtricitabine/tenofovir disoproxil fumarate

Brand Name: Truvada

Manufacturer: Gilead Sciences Canada Inc.

Therapeutic Area: HIV infection

Indications: HIV infection

Submission Type: Request For Advice

Project Status: Complete

Date Recommendation Issued: December 17, 2008

Recommendation Type: List with clinical criteria and/or conditions